LE WE PMID CA
Helicobacter pylori1120Helicobacter pylori

Actin

Agrobacterium tumefaciens

Anemia (Iron deficiency anemia)

Antibiotics (Resistance)

Bacteria (Secretion type IV)

Biliary system (Diseases)

Cell migration

Coxiella burnetii

DNA (Methylation)

Dyspepsia

Gastroesophageal reflux disease

Ghrelin

Helicobacter pylori

Hydrogen breath tests

Legionella

Neoplasia (Carcinogenesis)

Nod1

ORL (Neoplasia)

Platelets (Idiopathic thrombocytopenia ITP)

Probiotica

Rickettsiella grylli

Stomach (Neoplasia)

Ulcus pepticum

2000  
1
Regular review: treatment of Helicobacter pylori infection.
[10617524] BMJ 320(7226): 31-4 (2000)
1997  
2
Helicobacter pylori-associated gastroduodenal disease in childhood.
[9191731] South Med J 90(6): 570-6; quiz 577 (1997)
1998  
3
Current regimens for treatment of Helicobacter pylori infection.
[9604443] Br Med Bull 54(1): 195-205 (1998)
1998  
4
Microbiological and serological diagnostic tests for Helicobacter pylori: an overview.
[9604441] Br Med Bull 54(1): 175-86 (1998)
1998  
5
Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy.
[9604437] Br Med Bull 54(1): 121-38 (1998)
1998  
6
H. pylori virulence factors.
[9604436] Br Med Bull 54(1): 105-20 (1998)
1998  
7
Clinical significance of Helicobacter infection in children.
[9604435] Br Med Bull 54(1): 95-103 (1998)
1998  
8
Non-gastrointestinal consequences of Helicobacter pylori infection.
[9604434] Br Med Bull 54(1): 87-93 (1998)
1998  
9
Helicobacter pylori infection and gastric lymphoma.
[9604433] Br Med Bull 54(1): 79-85 (1998)
1998  
10
Helicobacter pylori infection and cancer.
[9604432] Br Med Bull 54(1): 71-8 (1998)
1998  
11
Helicobacter pylori infection and non-ulcer dyspepsia.
[9604431] Br Med Bull 54(1): 63-9 (1998)
1998  
12
Clinical science of Helicobacter pylori infection: ulcers and NSAIDs.
[9604430] Br Med Bull 54(1): 55-62 (1998)
1998  
13
Epidemiology of Helicobacter pylori: acquisition, transmission, population prevalence and disease-to-infection ratio.
[9604429] Br Med Bull 54(1): 39-53 (1998)
1998  
14
Helicobacter pylori--molecular genetics and diagnostic typing.
[9604428] Br Med Bull 54(1): 31-8 (1998)
1998  
15
Helicobacter--species classification and identification.
[9604427] Br Med Bull 54(1): 17-30 (1998)
2000  
16
Helicobacter pylori-related disease: guidelines for testing and treatment.
[10809031] Arch Intern Med 160(9): 1285-91 (2000)
1999  
17
Non-gastrointestinal tract associations of Helicobacter pylori infection.
[10326935] Arch Intern Med 159(9): 925-40 (1999)
1998  
18
Treatment of Helicobacter pylori infection.
[9570169] Arch Intern Med 158(8): 842-51 (1998)
2005  
19
A clinician's guide to managing Helicobacter pylori infection.
[15757167] Cleve Clin J Med 72(2): 109-10, 112-3, 117-8 passim (2005)
2008  
20
Helicobacter pylori--the latest in diagnosis and treatment.
[18704207] Aust Fam Physician 37(8): 608-12 (2008)
2009  
21
Helicobacter pylori and gastroduodenal ulcer disease.
[20038978] Dtsch Arztebl Int 106(49): 801-8 (2009)
1998  
22
Eradication of Helicobacter pylori infection in the management of patients with dyspepsia and non-ulcer dyspepsia.
[10378358] Yale J Biol Med 71(2): 125-33 (1998)
1998  
23
Treatment of H. pylori infection: the reality.
[10378357] Yale J Biol Med 71(2): 119-24 (1998)
1998  
24
Helicobacter pylori: therapeutic targets.
[10378356] Yale J Biol Med 71(2): 113-7 (1998)
1998  
25
Accuracy and economics of Helicobacter pylori diagnosis.
[10378352] Yale J Biol Med 71(2): 75-9 (1998)
1998  
26
Structure, function and localization of Helicobacter pylori urease.
[10378351] Yale J Biol Med 71(2): 63-73 (1998)
1998  
27
Helicobacter pylori and apoptosis.
[10378350] Yale J Biol Med 71(2): 53-61 (1998)
1998  
28
Pathobiology of Helicobacter pylori infection.
[10378349] Yale J Biol Med 71(2): 43-51 (1998)
1996  
29
Helicobacter pylori and its interaction with chief and parietal cells.
[9041695] Yale J Biol Med 69(1): 91-8 (1996)
1996  
30
Gastric MALT lymphoma and Helicobacter pylori.
[9041690] Yale J Biol Med 69(1): 61-8 (1996)
1996  
31
Helicobacter pylori: bacterial factors and interaction with the epithelial cells.
[9041687] Yale J Biol Med 69(1): 35-7 (1996)
1992  
32
Pathophysiology and clinical relevance of Helicobacter pylori.
[1341068] Yale J Biol Med 65(6): 625-38 (1992)
2003  
33
Diagnostic methods for Helicobacter pylori detection and eradication.
[12919175] Br J Clin Pharmacol 56(3): 273-83 (2003)
1997  
34
Eradication of Helicobacter pylori: an objective assessment of current therapies.
[9088577] Br J Clin Pharmacol 43(3): 223-43 (1997)
2009  
35
Helicobacter pylori infection in gastric cancerogenesis.
[19826177] J Physiol Pharmacol 60(3): 3-21 (2009)
2006  
36
Guidelines in the medical treatment of Helicobacter pylori infection.
[17033112] J Physiol Pharmacol 57 Suppl 3(-): 143-54 (2006)
2001  
37
Helicobacter pylori infection: epidemiology, pathophysiology, and therapy.
[11794521] Arch Pharm Res 24(6): 485-98 (2001)
1999  
38
Helicobacter pylori physiology predicted from genomic comparison of two strains.
[10477312] Microbiol Mol Biol Rev 63(3): 675-707 (1999)
1999  
39
Metabolism and genetics of Helicobacter pylori: the genome era.
[10477311] Microbiol Mol Biol Rev 63(3): 642-74 (1999)
2007  
40
Helicobacter pylori detection and antimicrobial susceptibility testing.
[17428887] Clin Microbiol Rev 20(2): 280-322 (2007)
2006  
41
Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses.
[17041136] Clin Microbiol Rev 19(4): 597-613 (2006)
2006  
42
Pathogenesis of Helicobacter pylori infection.
[16847081] Clin Microbiol Rev 19(3): 449-90 (2006)
2001  
43
Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases.
[11148003] Clin Microbiol Rev 14(1): 59-97 (2001)
1997  
44
2009  
45
Helicobacter pylori and gastric adenocarcinoma.
[19874380] Clin Microbiol Infect 15(11): 971-6 (2009)
2009  
46
Helicobacter pylori and gastric cancer: possible role of microRNAs in this intimate relationship.
[19702585] Clin Microbiol Infect 15(9): 806-12 (2009)
2005  
47
Pathogenicity of Helicobacter pylori infection.
[16008611] Clin Microbiol Infect 11(8): 602-10 (2005)
2003  
48
Non-invasive techniques for the diagnosis of Helicobacter pylori infection.
[12848723] Clin Microbiol Infect 9(6): 489-96 (2003)
1998  
49
Helicobacter pylori--a conundrum of genetic diversity.
[9846728] Microbiology 144 ( Pt 11)(-): 2925-39 (1998)
2009  
50
Helicobacter pylori's unconventional role in health and disease.
[19855816] PLoS Pathog 5(10): e1000544 (2009)
2006  
51
The diverse antioxidant systems of Helicobacter pylori.
[16879643] Mol Microbiol 61(4): 847-60 (2006)
2000  
52
Lewis antigens in Helicobacter pylori: biosynthesis and phase variation.
[10931272] Mol Microbiol 36(6): 1187-96 (2000)
2007  
53
Phagocytosis and persistence of Helicobacter pylori.
[17346311] Cell Microbiol 9(4): 817-28 (2007)
2000  
54
Helicobacter pylori: epidemiology and routes of transmission.
[11218379] Epidemiol Rev 22(2): 283-97 (2000)
2007  
55
Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori.
[17635369] Aliment Pharmacol Ther 26(3): 343-57 (2007)
2007  
56
Meta-analysis: Helicobacter pylori eradication treatment efficacy in children.
[17305754] Aliment Pharmacol Ther 25(5): 523-36 (2007)
2007  
57
Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy.
[17229240] Aliment Pharmacol Ther 25(2): 155-68 (2007)
2007  
58
Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer.
[17229238] Aliment Pharmacol Ther 25(2): 133-41 (2007)
2006  
59
Systematic review and meta-analysis: importance of CagA status for successful eradication of Helicobacter pylori infection.
[16842453] Aliment Pharmacol Ther 24(2): 273-80 (2006)
2006  
60
Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori?
[16611267] Aliment Pharmacol Ther 23(8): 1077-86 (2006)
2006  
61
Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure.
[16393278] Aliment Pharmacol Ther 23(1): 35-44 (2006)
2005  
62
A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses.
[15963079] Aliment Pharmacol Ther 22(1): 45-9 (2005)
2005  
63
Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
[15948807] Aliment Pharmacol Ther 21(12): 1411-8 (2005)
2005  
64
Controlled trial of interventions to increase testing and treatment for Helicobacter pylori and reduce medication use in patients with chronic acid-related symptoms.
[15813839] Aliment Pharmacol Ther 21(8): 1029-39 (2005)
2005  
65
Meta-analysis: the influence of pre-treatment with a proton pump inhibitor on Helicobacter pylori eradication.
[15709984] Aliment Pharmacol Ther 21(4): 341-5 (2005)
2005  
66
Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients.
[15644050] Aliment Pharmacol Ther 21(1): 91-6 (2005)
2004  
67
Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies.
[15569109] Aliment Pharmacol Ther 20(10): 1071-82 (2004)
2004  
68
Review article: is there a link between micronutrient malnutrition and Helicobacter pylori infection?
[15569104] Aliment Pharmacol Ther 20(10): 1029-34 (2004)
2004  
69
Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection -- a critical review.
[15569102] Aliment Pharmacol Ther 20(10): 1001-17 (2004)
2004  
70
Systematic review: the effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis.
[15379833] Aliment Pharmacol Ther 20(7): 733-44 (2004)
2004  
71
Review article: Deoxyribonucleic acid-based diagnostic techniques to detect Helicobacter pylori.
[15153166] Aliment Pharmacol Ther 19(11): 1137-46 (2004)
2003  
72
Meta-analysis: proton pump inhibitors vs. H2-receptor antagonists--their efficacy with antibiotics in Helicobacter pylori eradication.
[14535868] Aliment Pharmacol Ther 18(8): 757-66 (2003)
2003  
73
Meta-analysis: comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradication.
[12969092] Aliment Pharmacol Ther 18(6): 647-54 (2003)
2003  
74
Triple vs quadruple therapy for treating Helicobacter pylori infection: an updated meta-analysis.
[12950427] Aliment Pharmacol Ther 18(5): 543-4 (2003)
2003  
75
Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease.
[12895212] Aliment Pharmacol Ther 18(3): 279-89 (2003)
2003  
76
Review article: the treatment of refractory Helicobacter pylori infection.
[12786627] Aliment Pharmacol Ther 17(11): 1333-43 (2003)
2003  
77
Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis.
[12752350] Aliment Pharmacol Ther 17(9): 1137-43 (2003)
2003  
78
Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients.
[12492738] Aliment Pharmacol Ther 17(1): 99-109 (2003)
2002  
79
Alteration of histological gastritis after cure of Helicobacter pylori infection.
[12390101] Aliment Pharmacol Ther 16(11): 1923-32 (2002)
2002  
80
Effectiveness of Helicobacter pylori eradication treatments in a primary care setting in Italy.
[12144576] Aliment Pharmacol Ther 16(7): 1269-75 (2002)
2002  
81
Review article: Helicobacter pylori infection and gastric outlet obstruction - prevalence of the infection and role of antimicrobial treatment.
[12144568] Aliment Pharmacol Ther 16(7): 1203-8 (2002)
2002  
82
Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.
[12030945] Aliment Pharmacol Ther 16(6): 1047-57 (2002)
2002  
83
Review article: Helicobacter species and hepatobiliary diseases.
[12030944] Aliment Pharmacol Ther 16(6): 1037-45 (2002)
2002  
84
Review article: an approach to Helicobacter pylori infection in the elderly.
[11929385] Aliment Pharmacol Ther 16(4): 683-91 (2002)
2002  
85
Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies.
[11876712] Aliment Pharmacol Ther 16(3): 569-75 (2002)
2002  
86
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.
[11860399] Aliment Pharmacol Ther 16(2): 167-80 (2002)
2001  
87
A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer.
[11736726] Aliment Pharmacol Ther 15(12): 1949-58 (2001)
2001  
88
Review article: alternative antibacterial agents for Helicobacter pylori eradication.
[11563992] Aliment Pharmacol Ther 15(10): 1543-7 (2001)
2001  
89
pathogenesis of Helicobacter pylori-induced gastric inflammation.
[11552897] Aliment Pharmacol Ther 15(9): 1271-90 (2001)
2001  
90
Comparative efficacy of new investigational agents against Helicobacter pylori.
[11284777] Aliment Pharmacol Ther 15(4): 487-92 (2001)
2000  
91
Review article: the control of gastric acid and Helicobacter pylori eradication.
[11069309] Aliment Pharmacol Ther 14(11): 1383-401 (2000)
2000  
92
A systematic review of Helicobacter pylori eradication treatment schedules in children.
[11050489] Aliment Pharmacol Ther 14 Suppl 3(-): 59-66 (2000)
2000  
93
Treatment of Helicobacter pylori: an overview.
[11050481] Aliment Pharmacol Ther 14 Suppl 3(-): 1-6 (2000)
1999  
94
The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole.
[10383500] Aliment Pharmacol Ther 13(6): 719-29 (1999)
1999  
95
Review article: Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management.
[10102940] Aliment Pharmacol Ther 13(2): 117-27 (1999)
1998  
96
Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori.
[9768524] Aliment Pharmacol Ther 12(9): 823-37 (1998)
2009  
97
Meta-analysis: efficacy of bovine lactoferrin in Helicobacter pylori eradication.
[19183156] Aliment Pharmacol Ther 29(7): 720-30 (2009)
2008  
98
Meta-analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication.
[18644011] Aliment Pharmacol Ther 28(7): 868-77 (2008)
2004  
99
Histological aspects and role of mast cells in Helicobacter pylori-infected gastritis.
[15298623] Aliment Pharmacol Ther 20 Suppl 1(-): 165-70 (2004)
2002  
100
Review article: Helicobacter pylori infection from pathogenesis to treatment--a critical reappraisal.
[12047269] Aliment Pharmacol Ther 16 Suppl 4(-): 105-13 (2002)
2002  
101
Review article: natural history and epidemiology of Helicobacter pylori infection.
[11849122] Aliment Pharmacol Ther 16 Suppl 1(-): 3-15 (2002)
1997  
102
Review article: urea breath tests for detecting Helicobacter pylori.
[9305471] Aliment Pharmacol Ther 11(4): 641-9 (1997)
1997  
103
Gastric MALT-lymphoma and Helicobacter pylori infection.
[9146794] Aliment Pharmacol Ther 11 Suppl 1(-): 89-94 (1997)
1997  
104
Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer.
[9146793] Aliment Pharmacol Ther 11 Suppl 1(-): 71-88 (1997)
2006  
105
Genetic factors involved in the development of Helicobacter pylori-related gastric cancer.
[16879717] Cancer Sci 97(11): 1129-38 (2006)
2005  
106
Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis.
[16367902] Cancer Sci 96(12): 835-43 (2005)
2005  
107
Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of the literature.
[15682423] Am J Hematol 78(2): 142-50 (2005)
1999  
108
Molecular and cellular activities of Helicobacter pylori pathogenic factors.
[10376670] FEBS Lett 452(1-2): 16-21 (1999)
2006  
109
Use and abuse of hydrogen breath tests.
[16474100] Gut 55(3): 297-303 (2006)
2004  
110
H pylori antibiotic resistance: prevalence, importance, and advances in testing.
[15306603] Gut 53(9): 1374-84 (2004)
2002  
111
The non-H pylori helicobacters: their expanding role in gastrointestinal and systemic diseases.
[11788573] Gut 50(2): 273-83 (2002)
2001  
112
Non-pylori Helicobacter species in humans.
[11600455] Gut 49(5): 601-6 (2001)
1999  
113
Extradigestive manifestations of Helicobacter pylori gastric infection.
[10457029] Gut 45 Suppl 1(-): I9-I12 (1999)
1999  
114
Are all helicobacters equal? Mechanisms of gastroduodenal pathology and their clinical implications.
[10457027] Gut 45 Suppl 1(-): I1-4 (1999)
1998  
115
Helicobacters are indigenous to the human stomach: duodenal ulceration is due to changes in gastric microecology in the modern era.
[9824358] Gut 43(5): 721-7 (1998)
2009  
116
Azithromycin-containing versus standard triple therapy for Helicobacter pylori eradication: a meta-analysis.
[20027685] World J Gastroenterol 15(48): 6102-10 (2009)
2009  
117
Comparative genomics of Helicobacter pylori.
[19705492] World J Gastroenterol 15(32): 3984-91 (2009)
2008  
118
"Rescue" regimens after Helicobacter pylori treatment failure.
[18803350] World J Gastroenterol 14(35): 5385-402 (2008)
2006  
119
Precise role of H pylori in duodenal ulceration.
[17072972] World J Gastroenterol 12(40): 6413-9 (2006)
2006  
120
Third-line rescue therapy for Helicobacter pylori infection.
[16688818] World J Gastroenterol 12(15): 2313-9 (2006)
2006  
121
Causal role of Helicobacter pylori infection and eradication therapy in gastric carcinogenesis.
[16440410] World J Gastroenterol 12(1): 10-6 (2006)
2003  
122
Helicobacter pylori. Pathology and diagnostic strategies.
[12645343] Am J Clin Pathol 119(3): 403-12 (2003)
1997  
123
Evolving therapy for Helicobacter pylori infection: efficacy and economic impact in the treatment of patients with duodenal ulcer disease.
[10178459] Am J Manag Care 3(10): 1528-34 (1997)
2008  
124
Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment.
[18490667] Ann Intern Med 148(12): 923-31 (2008)
2008  
125
Sequential therapy for Helicobacter pylori: a worthwhile effort for your patients.
[18490666] Ann Intern Med 148(12): 962-3 (2008)
2007  
126
Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication.
[17938394] Ann Intern Med 147(8): 553-62 (2007)
2006  
127
Improving Helicobacter pylori eradication regimens.
[16418415] Ann Intern Med 144(2): 140-1 (2006)
2001  
128
Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials.
[11242496] Ann Intern Med 134(5): 361-9 (2001)
1997  
129
Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences.
[9036800] Ann Intern Med 126(4): 280-91 (1997)
2009  
130
Moxifloxacin-based triple therapy versus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection: a meta-analysis of randomized controlled trials.
[20009394] Intern Med 48(24): 2069-76 (2009)
2000  
131
Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori infection: evaluation of antibiotic treatment.
[10801137] Intern Med 39(4): 273-4 (2000)
2004  
132
Helicobacter pylori persistence: biology and disease.
[14755326] J Clin Invest 113(3): 321-33 (2004)
1990  
133
Helicobacter pylori (formerly Campylobacter pyloridis/pylori) 1986-1989: a review.
[2196282] J Clin Pathol 43(5): 353-6 (1990)
2003  
134
Current consensus on the diagnosis and treatment of H. pylori-associated gastroduodenal disease.
[14529149] Keio J Med 52(3): 163-73 (2003)
2000  
135
1992  
136
Eradication of Helicobacter pylori: therapies and clinical implications.
[1437952] Postgrad Med J 68(801): 549-57 (1992)
1998  
137
Procedure guideline for carbon-14-urea breath test. Society of Nuclear Medicine.
[9829599] J Nucl Med 39(11): 2012-4 (1998)
1997  
138
Helicobacter pylori: new developments and treatments.
[9176424] CMAJ 156(11): 1565-74 (1997)
1994  
139
Indications for treatment of Helicobacter pylori infection: a systematic overview.
[8287341] CMAJ 150(2): 189-98 (1994)
1994  
140
Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview.
[8287340] CMAJ 150(2): 177-85 (1994)
2003  
141
Systematic review: Rabeprazole-based therapies in Helicobacter pylori eradication.
[12641497] Aliment Pharmacol Ther 17(6): 751-64 (2003)
2005  
142
Events at the host-microbial interface of the gastrointestinal tract IV. The pathogenesis of Helicobacter pylori persistence.
[15961885] Am J Physiol Gastrointest Liver Physiol 289(1): G8-12 (2005)
2004  
143
2010  
144
Association between helicobacter pylori and gastrointestinal symptoms in children.
[20156901] Pediatrics 125(3): e651-69 (2010)
2010  
145
First-line eradication of Helicobacter pylori: are the standard triple therapies obsolete? A different perspective.
[20712046] World J Gastroenterol 16(31): 3865-70 (2010)
2011  
146
Helicobacter pylori neutrophil activating protein as target for new drugs against H. pylori inflammation.
[21677824] World J Gastroenterol 17(21): 2585-91 (2011)
2011  
147
Molecular cross-talk between Helicobacter pylori and human gastric mucosa.
[21472096] World J Gastroenterol 17(11): 1383-99 (2011)
2011  
148
Endocrine impact of Helicobacter pylori: focus on ghrelin and ghrelin o-acyltransferase.
[21455323] World J Gastroenterol 17(10): 1249-60 (2011)
2011  
149
A new look at anti-Helicobacter pylori therapy.
[22046084] World J Gastroenterol 17(35): 3971-5 (2011)
2007  
150
Diet, H pylori infection and gastric cancer: evidence and controversies.
[17589938] World J Gastroenterol 13(21): 2901-12 (2007)
2007  
151
Emerging role of IL-23/IL-17 axis in H pylori-associated pathology.
[17948927] World J Gastroenterol 13(42): 5547-51 (2007)
2005  
152
Acid acclimation by Helicobacter pylori.
[16287992] Physiology (Bethesda) 20(-): 429-38 (2005)
2010  
153
Cytotoxic T cells in H. pylori-related gastric autoimmunity and gastric lymphoma.
[20617132] J Biomed Biotechnol 2010(-): 104918 (2010)
2009  
154
Coadaptation of Helicobacter pylori and humans: ancient history, modern implications.
[19729845] J Clin Invest 119(9): 2475-87 (2009)
2010  
155
Role of innate immunity in Helicobacter pylori-induced gastric malignancy.
[20664074] Physiol Rev 90(3): 831-58 (2010)
2007  
156
The language used by Helicobacter pylori to regulate human cells.
[17538876] J Infect Dis 196(1): 6-9 (2007)
2010  
157
Helicobacter pylori and gastric cancer: factors that modulate disease risk.
[20930071] Clin Microbiol Rev 23(4): 713-39 (2010)
2008  
158
Use of NSAIDs and infection with Helicobacter pylori--what does the rheumatologist need to know?
[18477642] Rheumatology (Oxford) 47(9): 1342-7 (2008)
2010  
159
Iron deficiency anaemia can be improved after eradication of Helicobacter pylori.
[20448223] Postgrad Med J 86(1015): 272-8 (2010)
2004  
160
Eradication of Helicobacter pylori: a clinical update.
[15208531] MedGenMed 6(1): 19 (2004)
2007  
161
Type IV secretion system in Helicobacter pylori: a new insight into pathogenicity.
[18167190] Chin Med J (Engl) 120(23): 2138-42 (2007)
2002  
162
Risks and benefits of Helicobacter pylori eradication: current status.
[11826340] Can J Gastroenterol 16(1): 57-62 (2002)
2011  
163
Helicobacter pylori treatment in the hospital setting: a potential model for developing quality improvement initiatives to prevent missed test results.
[22059157] Can J Gastroenterol 25(10): 542 (2011)
2004  
164
Helicobacter pylori and the prevention of gastric cancer.
[15152278] Can J Gastroenterol 18(5): 295-302 (2004)
2005  
165
An update on anti-Helicobacter pylori treatment in children.
[16010308] Can J Gastroenterol 19(7): 441-5 (2005)
2005  
166
Noninvasive diagnostic tests for Helicobacter pylori infection in children.
[16010307] Can J Gastroenterol 19(7): 433-9 (2005)
2005  
167
Extradigestive manifestation of Helicobacter pylori infection in children and adolescents.
[16010304] Can J Gastroenterol 19(7): 421-4 (2005)
2005  
168
Modulation of host cell signal transduction pathways by Helicobacter pylori infection.
[16010303] Can J Gastroenterol 19(7): 415-20 (2005)
2010  
169
Helicobacter pylori infection, oncogenic pathways and epigenetic mechanisms in gastric carcinogenesis.
[20465395] Future Oncol 6(5): 851-62 (2010)
2007  
170
Helicobacter pylori in children: an Indian perspective.
[17998576] Indian Pediatr 44(10): 761-70 (2007)
2009  
171
Infection with Helicobacter pylori. Prevalence, research and impact of antibiotic resistance.
[20001151] Rev Esp Enferm Dig 101(11): 743-56 (2009)
2006  
172
Gastric angiogenesis and Helicobacter pylori infection.
[17022702] Rev Esp Enferm Dig 98(7): 527-41 (2006)
2009  
173
Current knowledge on helicobacter pylori infection in end stage renal disease patients.
[19861855] Saudi J Kidney Dis Transpl 20(6): 969-74 (2009)
2011  
174
Helicobacter pylori molecular diagnosis.
[21545252] Expert Rev Mol Diagn 11(4): 351-5 (2011)
2002  
175
Dental implications of Helicobacter pylori.
[12323105] J Can Dent Assoc 68(8): 489-93 (2002)
2007  
176
Helicobacter bilis: bacterial provocateur orchestrates host immune responses to commensal flora in a model of inflammatory bowel disease.
[17566023] Gut 56(7): 898-900 (2007)
2007  
177
The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis.
[17566020] Gut 56(10): 1353-7 (2007)
2007  
178
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.
[17170018] Gut 56(6): 772-81 (2007)
2011  
179
Should quinolones come first in Helicobacter pylori therapy?
[21694812] Therap Adv Gastroenterol 4(2): 103-14 (2011)
2011  
180
Type IVB Secretion Systems of Legionella and Other Gram-Negative Bacteria.
[21743810] Front Microbiol 2(-): 136 (2011)
2010  
181
Pleiotropic actions of Helicobacter pylori vacuolating cytotoxin, VacA.
[20046046] Tohoku J Exp Med 220(1): 3-14 (2010)
2009  
182
Efficient identification and evaluation of effective Helicobacter pylori therapies.
[19026766] Clin Gastroenterol Hepatol 7(2): 145-8 (2009)
2010  
183
Mechanisms of disease: Helicobacter pylori virulence factors.
[20938460] Nat Rev Gastroenterol Hepatol 7(11): 629-41 (2010)
2010  
184
Gastroesophageal Reflux Disease and Helicobacter pylori: What May Be the Relationship?
[20680162] J Neurogastroenterol Motil 16(3): 243-50 (2010)
2011  
185
What is the difference between Helicobacter pylori-associated dyspepsia and functional dyspepsia?
[21602988] J Neurogastroenterol Motil 17(2): 124-30 (2011)
2011  
186
How to interpret hydrogen breath tests.
[21860825] J Neurogastroenterol Motil 17(3): 312-7 (2011)
2007  
187
Helicobacter pylori: present status and future prospects in Japan.
[17322988] J Gastroenterol 42(1): 1-15 (2007)
2009  
188
Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication.
[19298338] Helicobacter 14(2): 109-18 (2009)
2006  
189
Helicobacter pylori infection in pathogenesis of gastroesophageal reflux disease.
[17033107] J Physiol Pharmacol 57 Suppl 3(-): 81-90 (2006)
2006  
190
Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
[17033106] J Physiol Pharmacol 57 Suppl 3(-): 67-79 (2006)
2006  
191
Gastric cancer and Helicobacter pylori infection.
[17033105] J Physiol Pharmacol 57 Suppl 3(-): 51-65 (2006)
2006  
192
Helicobacter pylori and its involvement in gastritis and peptic ulcer formation.
[17033104] J Physiol Pharmacol 57 Suppl 3(-): 29-50 (2006)
2006  
193
Interplay between Helicobacter pylori and the immune system. Clinical implications.
[17033103] J Physiol Pharmacol 57 Suppl 3(-): 15-27 (2006)
2006  
194
Helicobacter pylori: microbiology and interactions with gastrointestinal microflora.
[17033102] J Physiol Pharmacol 57 Suppl 3(-): 5-14 (2006)
2010  
195
Management of Helicobacter pylori.
[20948865] F1000 Med Rep 2(-): - (2010)
2007  
196
Epigenetic field for cancerization.
[17394762] J Biochem Mol Biol 40(2): 142-50 (2007)
2011  
197
H. pylori exploits and manipulates innate and adaptive immune cell signaling pathways to establish persistent infection.
[22044597] Cell Commun Signal 9(1): 25 (2011)
2011  
198
Regulation of the actin cytoskeleton in Helicobacter pylori-induced migration and invasive growth of gastric epithelial cells.
[22044652] Cell Commun Signal 9(1): 27 (2011)
2011  
199
"Targeted disruption of the epithelial-barrier by Helicobacter pylori".
[22044698] Cell Commun Signal 9(1): 29 (2011)
2007  
200
Helicobacter pylori is invasive and it may be a facultative intracellular organism.
[17388791] Cell Microbiol 9(5): 1108-16 (2007)
2010  
201
NOD1-Mediated Mucosal Host Defense against Helicobacter pylori.
[21152124] Int J Inflam 2010(-): 476482 (2010)
2005  
202
Helicobacter pylori and gastric cancer: what can be learned by studying the response of gastric epithelial cells to the infection?
[16103426] Cancer Epidemiol Biomarkers Prev 14(8): 1859-64 (2005)
2005  
203
The biology of Helicobacter pylori infection, a major risk factor for gastric adenocarcinoma.
[16103425] Cancer Epidemiol Biomarkers Prev 14(8): 1853-8 (2005)
2008  
204
Helicobacter pylori in tonsillar and adenoid tissue and its possible role in oropharyngeal carcinogenesis.
[18498719] Folia Biol (Praha) 54(2): 33-9 (2008)
2011  
205
Mechanisms of Helicobacter pylori antibiotic resistance: An updated appraisal.
[21860834] World J Gastrointest Pathophysiol 2(3): 35-41 (2011)
2010  
206
Worldwide H. pylori antibiotic resistance: a systematic review.
[21188333] J Gastrointestin Liver Dis 19(4): 409-14 (2010)
PMC   
207
A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication.
[24587620] World J Gastroenterol 20(6):1438-49 (2014)
PMC   
208
Second-line and third-line trial for helicobacter pylori infection in patients with duodenal ulcers: A prospective, crossover, controlled study.
[24764586] Curr Ther Res Clin Exp 65(1):13-25 (2004)
PMC   
209
Helicobacter pylori and Systemic Disease.
[24772167] Gastroenterol Res Pract 2014():358494 (2014)
PMC   
210
Comparative study of esomeprazole and lansoprazole in triple therapy for eradication of Helicobacter pylori in Japan.
[24764674] World J Gastroenterol 20(15):4362-9 (2014)
PMC   
211
Does Helicobacter pylori protect against asthma and allergy?
[18194986] Gut 57(5):561-7 (2008)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


  • Helicobacter pylori und gastroduodenale Ulkuskrankheit


  • Search PubMed and many other databases on the combined search terms

    GG: helicobacter pylori

  • Helicobacter pylori

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia